STAB Statera Biopharma Inc

NASDAQ
$0.00

Statera Biopharma Inc (STAB) is expected to report earnings on October 19, 2026, after the market close.

Earnings Date
Oct 19
Monday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Statera Biopharma Inc

Statera BioPharma is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. Statera BioPharma, formerly known as Cytocom Inc., is based in FORT COLLINS, Colo.

Charts powered in part by Lightweight Charts™ by TradingView.